SPOTLIGHT: More good news for Alzheimer's patients

Don't plan the party yet, but there's more good news for Alzheimer's patients and statin makers alike. New research that combined cognitive monitoring before death and brain dissection afterward shows that seniors who'd taken statin drugs to lower their cholesterol had developed fewer of the protein deposits in their brains that are the hallmarks of Alzheimer's Disease. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.